Additional analysis of data from the NAVIGATE trial showed statistically significant 68.1% (p=0.02) reduction in the incidence of new varices with belapectin vs placebo in per-protocol patients ...

Anivive, a software-driven pet health company, today announced the successful completion of its pivotal field study evaluating the safety and effectiveness of LAVERDIA®-CA1 (verdinexor tablets) in ...

MONTREAL — Hockey Quebec is banning the use of smelling salts, citing concern over their use by young players. The governing ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

This article is sponsored by Incyte. Lisa was compensated for her time participating in the interview. For Lisa, life with nonsegmental vitiligo has been a roller coaster of emotions. Navigating ...

British rocker and Placebo frontman Brian Molko has been charged with defamation after hurling insults at the Italian Prime ...

A new study suggests that daily taxifolin intake may support weight loss in older adults, possibly through brown fat ...

Chemomab Therapeutics (CMMB) announced the successful completion of its End-of-Phase 2 Meeting with the FDA and alignment with FDA on the ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...

Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...